• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Authors » Varun Saxena

Varun Saxena

Articles

ARTICLES

Canon makes bet on molecular diagnostics with $40M investment in T2 Biosystems

Sep. 23, 2016
By Varun Saxena
The stock of molecular diagnostics company T2 Biosystems Inc. spiked 10 percent due to a $40 million equity investment from Melville, N.Y.-based Canon U.S.A. Inc., made in return for a nearly 20 percent stake in the firm.
Read More

FDA adjusting its regulation of neurological devices to keep pace with new med tech

Sep. 15, 2016
By Varun Saxena
The FDA is making review and regulation of neurological devices a priority, thanks to the plethora of innovative med tech related to brain conditions, such as stent retrievers for treating stroke. Other recently approved devices include the Deka Arm System, the first prosthetic arm that translates signals from an individual's muscles to perform tasks, and the first medical device to prevent migraines, dubbed Cefaly.
Read More

Boston Scientific backs venous stent maker Veniti in $25 million series D funding round

Sep. 9, 2016
By Varun Saxena
Marlborough, Mass.-based Boston Scientific Corp. is backing a venous stent maker to the tune of $25 million in equity financing, making it the largest investor in the company. The series D round is expected to enable St. Louis-based Veniti Inc. to complete a U.S. clinical trial of its Vici Venous Stent System.
Read More

Senators make a push for incorporation of unique device identifiers into insurance claims forms

Sep. 6, 2016
By Varun Saxena

Using RNA assays, FDA to expand testing of donated blood for Zika across the U.S.

Aug. 29, 2016
By Varun Saxena
The FDA is recommending nationwide testing of donated blood for the Zika virus in a bid to eliminate another transmission vector of the disease. Zika can cause pregnant women to give birth to babies with abnormally small heads, a condition known as microcephaly, or other brain defects.
Read More

Orasure to receive up to $16.6M in federal funding to develop its Zika diagnostic

Aug. 25, 2016
By Varun Saxena
As the government ramps up its response to the Zika virus scare, Bethlehem, Pa.-based Orasure Technologies Inc. will receive up to $16.6 million from the U.S. Department of Health and Human Services to develop a rapid molecular diagnostic that tests for the disease's antibodies. The funding comes from the agency's Biomedical Advanced Research and Development Authority.
Read More

Spanish researchers develop vision simulator for intraocular lens selection

Aug. 19, 2016
By Varun Saxena

Lack of funding threatens Titan's robotic surgery ambitions, now in dash for cash

Aug. 17, 2016
By Varun Saxena
Toronto-based Titan Medical Inc. is facing a shortage of R&D funding for its single-port Sport Surgical System robotic surgery device. The company is now scrambling for cash instead of FDA clearance.
Read More

Foreign devices excluded from China's new expedited review for high-priority med tech

Aug. 15, 2016
By Varun Saxena
Over the summer the CFDA proposed a new expedited review program for high-priority devices, but it excludes foreign devices from participation, to the chagrin of industry players around the world.
Read More

Myriad enters neuroscience diagnostics market with $225 million Assurex buy

Aug. 5, 2016
By Varun Saxena
View All Articles by Varun Saxena

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 8, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 8, 2025.
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 8, 2025
  • Kidney disease illustration

    Prokidney produces positive phase II CKD data, thunderous stock surge

    BioWorld
    A mixed bag of top-line phase II data prompted stellar stock results for Prokidney Corp. and its chronic kidney disease (CKD) and diabetes therapy, rilparencel....
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe